500 studies found for:    lupus
Show Display Options
RSS Create an RSS feed from your search for:
lupus
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
Etanercept for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Etanercept;   Drug: Lupus Treatment- Standard of Care;   Drug: Placebo
2 Active, not recruiting Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions: Drug: Abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
3 Completed Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
Conditions: SLE;   Lupus Nephritis;   Renal Insufficiency;   End-stage Renal Disease
Interventions: Drug: Tacrolimus;   Drug: cyclophosphamide
4 Recruiting Functional MRI in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
5 Completed CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)
Condition: Systemic Lupus Erythematosus
Intervention:
6 Unknown  Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
Conditions: Cutaneous Lupus;   Discoid Lupus;   Lupus;   Systemic Lupus Erythematosus
Interventions: Drug: AMG811;   Drug: AMG811 Placebo
7 Completed A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus
Conditions: Metabolic Syndrome;   Cardiovascular Risk Factors;   Systemic Lupus Erythematosus
Intervention:
8 Terminated Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
Condition: Subacute Cutaneous Lupus Erythematosus
Interventions: Drug: KRP203 - 1.2mg;   Drug: Placebo to KRP203 - 1.2 mg
9 Completed
Has Results
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare
Condition: Lupus Nephritis
Interventions: Drug: Mycophenolate sodium;   Drug: Prednisone;   Drug: Methylprednisolone
10 Completed Anti-CD20 in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: Rituximab
11 Completed Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Condition: Systemic Lupus Erythematosus
Intervention: Drug: atorvastatin
12 Completed Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Condition: Lupus Nephritis
Intervention:
13 Completed Study of Methotrexate in Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Methotrexate and folic acid
14 Completed Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Interventions: Drug: Pimecrolimus 1% cream;   Drug: betamethasone valerate 0.1% cream
15 Completed A Non-drug Study Profiling Cutaneous Lupus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid
Interventions: Procedure: No intervention, skin biopsy;   Procedure: No intervention, blood collection;   Procedure: No intervention, urine collection
16 Unknown  The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: mycophenolate sodium;   Drug: cyclophosphamide
17 Completed Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: CTLA4-IgG4m (RG2077);   Drug: Cyclophosphamide
18 Terminated A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: CEP-33457
19 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
20 Completed A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Interventions: Drug: 1 mg/kg CNTO 136;   Drug: 4 mg/kg CNTO 136;   Drug: 10 mg/kg CNTO 136;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years